Ganciclovir for Injection, USP is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for the: treatment of CMV retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS). prevention of CMV disease in adult transplant recipients at risk for CMV disease.
From the U.S. FDA-approved label for Ganciclovir. Full label: DailyMed.
Ganciclovir for Injection, USP is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for the: treatment of CMV retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS). prevention of CMV disease in adult transplant recipients at risk for CMV disease.
From the U.S. FDA-approved label for Ganciclovir. Full label: DailyMed.
Ganciclovir for injection is administered only intravenously. Dosage in Adult Patients with Normal Renal Function Treatment of CMV retinitis Induction: 5 mg/kg (given intravenously at a constant rate over 1 hour) every 12 hours for 14 to 21 days. Maintenance: 5 mg/kg (given intravenously at a constant rate over 1 hour) once daily for 7 days per week, or 6 mg/kg once daily for 5 days per week.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Ganciclovir for injection is contraindicated in patients who have experienced a clinically significant hypersensitivity reaction (e.g., anaphylaxis) to ganciclovir, valganciclovir, or any component of the formulation. Hypersensitivity to ganciclovir or valganciclovir.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Renal Impairment: Increased serum creatinine levels have been observed with the use of ganciclovir, particularly in elderly patients and transplant recipients receiving concomitant nephrotoxic drugs. Monitor renal function during therapy with ganciclovir, particularly in elderly patients and in patients taking other nephrotoxic drugs, and reduce dosage in patients with renal impairment. 5.1 Hematologic Toxicity Granulocytopenia (neutropenia), anemia, thrombocytopenia and pancytopenia have been observed in patients treated with ganciclovir.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are discussed in greater detail in other sections of the labeling: Hematologic Toxicity Renal Impairment Impairment of Fertility Fetal Toxicity Mutagenesis and Carcinogenesis Most common adverse reactions and laboratory abnormalities reported in at least 20% of patients were: pyrexia, diarrhea, leukopenia, nausea, anemia, asthenia, headache, cough, decreased appetite, dyspnea, abdominal…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
20 products from 18 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Clygan 1.5mg Gel | Ganciclovir (1.5mg) | Indoco Remedies Ltd | tube of 5 gm Ophthalmic Gel |
| Cymevene 500mg Injection | Ganciclovir (500mg) | Roche Products India Pvt Ltd | vial of 1 Injection |
| Gancigel Ophthalmic Gel | Ganciclovir (1.5mg) | Entod Pharmaceuticals Ltd | tube of 5 gm Ophthalmic Gel |
| Gancor Eye Gel | Ganciclovir (0.15% w/w) | Choroid Laboratories | tube of 5 gm Ophthalmic Gel |
| Ganguard 500mg Capsule | Ganciclovir (500mg) | Sun Pharmaceutical Industries Ltd | strip of 10 capsules |
| Ganpyar Eye Gel | Ganciclovir (1.5mg) | Austrak Pvt Ltd | bottle of 5 gm Eye Gel |
| Gansac Eye Gel | Ganciclovir (1.5mg) | Doctor Wonder Private Limited | tube of 5 gm Eye Gel |
| Gansecure Eye Gel | Ganciclovir (1.5mg) | Micro Labs Ltd | tube of 5 gm Ophthalmic Gel |
| Ganvir Ophthalmic Gel | Ganciclovir (0.15% w/w) | Maa Enterprise | tube of 5 gm Ophthalmic Gel |
| Gatlevir Eye Gel | Ganciclovir (0.15% w/v) | Gatle Healthcare Ltd | tube of 5 gm Eye Gel |
| Gavir 250 Capsule | Ganciclovir (250mg) | United Biotech Pvt Ltd | strip of 8 capsules |
| Gelovir Eye Gel | Ganciclovir (0.15% w/w) | Nri Vision Care India Limited | tube of 5 gm Ophthalmic Gel |
| Natclovir 250 Capsule | Ganciclovir (250mg) | Natco Pharma Ltd | strip of 10 capsules |
| Natclovir 250mg Injection | Ganciclovir (250mg) | Natco Pharma Ltd | vial of 1 Injection |
| Natclovir 500mg Injection | Ganciclovir (500mg) | Natco Pharma Ltd | vial of 10 ml Injection |
| Simplovir 1.5mg Gel | Ganciclovir (1.5mg) | Sunways India Pvt Ltd | tube of 5 gm Ophthalmic Gel |
| Vira-G Eye Gel | Ganciclovir (0.15% w/w) | Pharmatak Opthalmics Pvt Ltd | tube of 5 gm Ophthalmic Gel |
| Virset G 0.15% Ophthalmic Gel | Ganciclovir (0.15% w/w) | Amwin Pharmaceuticals | tube of 5 gm Ophthalmic Gel |
| Virson Ophthalmic Gel | Ganciclovir (1.5mg) | Ajanta Pharma Ltd | tube of 5 gm Ophthalmic Gel |
| Vitravene 250mg Capsule | Ganciclovir (250mg) | Taj Pharma India Ltd | strip of 10 capsules |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage Store at 20° to 25°C (68° to 77°F). Store reconstituted solution in the vial at 25°C (77°F) for no longer than 12 hours. Store diluted infusion solution under refrigeration at 2° to 8°C (36° to 46°F) for no longer than 24 hours.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
